Your session is about to expire
← Back to Search
Care Coordination Program for Dementia (Co-CARE-AD Trial)
N/A
Waitlist Available
Led By Richard Platt, MD MS
Research Sponsored by Harvard Pilgrim Health Care
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Community-dwelling Tufts Health Plan Medicare Advantage members with ADRD and their caregivers will be selected to participate in the trial based on the following inclusion/
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up by 6 months
Awards & highlights
Co-CARE-AD Trial Summary
This trial will compare a collaborative care-coordination program to usual care for people living with Alzheimer's disease and related dementias (ADRD) and their care partners. Outcomes will include healthcare utilization outcomes of individuals with ADRD.
Who is the study for?
This trial is for community-dwelling individuals enrolled in the Tufts Health Plan Medicare Advantage who have Alzheimer's disease or related dementias, along with their caregivers. Participants must meet certain health plan criteria to join.Check my eligibility
What is being tested?
The study is testing a Dementia Care Consultation program designed to help manage Alzheimer's and related dementias. It compares this new care-coordination approach against the usual healthcare services provided by the health plan.See study design
What are the potential side effects?
Since this trial involves a care coordination program rather than medication, there are no direct medical side effects. However, participants may experience changes in healthcare utilization like more or fewer doctor visits.
Co-CARE-AD Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowCo-CARE-AD Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ by 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~by 6 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
All-cause emergency department visits
Secondary outcome measures
Admission to long-term care facilities
Avoidable emergency department visits
Outpatient visits
Co-CARE-AD Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Dementia Care Consultation programExperimental Treatment1 Intervention
The Dementia Care Consultation program provides an in-depth, personalized service for individuals and families facing ADRD.
Group II: Routine CareActive Control1 Intervention
Members randomized into the control group will receive routine care.
Find a Location
Who is running the clinical trial?
Harvard Pilgrim Health CareLead Sponsor
54 Previous Clinical Trials
27,778,818 Total Patients Enrolled
Tufts Health PlanUNKNOWN
National Institute on Aging (NIA)NIH
1,668 Previous Clinical Trials
28,002,904 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:Research Study Groups:
This trial has the following groups:- Group 1: Dementia Care Consultation program
- Group 2: Routine Care
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Does this medical experiment currently require additional participants?
"Affirmative. The clinicaltrials.gov database shows that recruitment for this trial is ongoing, with the initial posting having been made on May 27th 2022 and a subsequent update occurring November 14th of the same year. This initiative seeks to recruit 2160 participants from one medical institution."
Answered by AI
How extensive is the scope of this research involving patients?
"Affirmative. Information posted on clinicaltrials.gov confirms that this medical exploration, which was first listed on May 27th 2022, is currently recruiting participants. A total of 2160 patients are needed from 1 specific location."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger